These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31422453)

  • 41. Longitudinal analysis of cognitive performances in recent-onset and late-life Bipolar Disorder: A systematic review and meta-analysis.
    Szmulewicz A; Valerio MP; Martino DJ
    Bipolar Disord; 2020 Feb; 22(1):28-37. PubMed ID: 31541587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Course of longitudinal psychosocial functioning in bipolar youth transitioning to adults.
    Lee EJ; Hower H; Jones RN; Birmaher B; Strober M; Goldstein BI; Merranko J; Keller MB; Goldstein TR; Weinstock LM; Dickstein DP; Hunt JI; Diler RS; Ryan ND; Gill MK; Axelson D; Yen S
    J Affect Disord; 2020 May; 268():109-117. PubMed ID: 32158000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and determinants of cognitive impairment in the euthymic phase of bipolar disorders: results from the FACE-BD cohort.
    Roux P; Etain B; Cannavo AS; Aubin V; Aouizerate B; Azorin JM; Bellivier F; Belzeaux R; Bougerol T; Cussac I; Courtet P; Kahn JP; Leboyer M; M'Bailara K; Payet MP; Olié E; ; Henry C; Passerieux C
    Psychol Med; 2019 Feb; 49(3):519-527. PubMed ID: 29734950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manic morbidity and executive function impairment as determinants of long-term psychosocial dysfunction in bipolar disorder.
    Lomastro MJ; Valerio MP; Szmulewicz AG; Martino DJ
    Acta Psychiatr Scand; 2021 Jul; 144(1):72-81. PubMed ID: 33792890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between residual depressive symptoms, cognition, and functioning in patients with euthymic bipolar disorder: results from the FACE-BD cohort.
    Roux P; Raust A; Cannavo AS; Aubin V; Aouizerate B; Azorin JM; Bellivier F; Belzeaux R; Bougerol T; Cussac I; Courtet P; Etain B; Gard S; Job S; Kahn JP; Leboyer M; Olié E; ; Henry C; Passerieux C
    Br J Psychiatry; 2017 Dec; 211(6):381-387. PubMed ID: 29051175
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuropsychological Clustering in Bipolar and Major Depressive Disorder.
    Cotrena C; Damiani Branco L; Ponsoni A; Milman Shansis F; Paz Fonseca R
    J Int Neuropsychol Soc; 2017 Aug; 23(7):584-593. PubMed ID: 28762320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.
    Luperdi SC; Tabarés-Seisdedos R; Livianos L; Vieta E; Cuesta MJ; Balanzá-Martínez V
    Schizophr Res; 2019 Aug; 210():21-29. PubMed ID: 31272906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal relationships between cognition and functioning over 2 years in euthymic patients with bipolar disorder: a cross-lagged panel model approach with the FACE-BD cohort.
    Ehrminger M; Brunet-Gouet E; Cannavo AS; Aouizerate B; Cussac I; Azorin JM; Bellivier F; Bougerol T; Courtet P; Dubertret C; Etain B; Kahn JP; Leboyer M; Olié E; ; Passerieux C; Roux P
    Br J Psychiatry; 2021 Feb; 218(2):80-87. PubMed ID: 31407639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurocognition, functional outcome, and quality of life in remitted and non-remitted schizophrenia: A comparison with euthymic bipolar I disorder and a control group.
    Jiménez-López E; Villanueva-Romero CM; Sánchez-Morla EM; Martínez-Vizcaíno V; Ortiz M; Rodriguez-Jimenez R; Vieta E; Santos JL
    Schizophr Res; 2022 Feb; 240():81-91. PubMed ID: 34991042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying cognitive subgroups in bipolar disorder: A cluster analysis.
    Lima F; Rabelo-da-Ponte FD; Bücker J; Czepielewski L; Hasse-Sousa M; Telesca R; Solé B; Reinares M; Vieta E; Rosa AR
    J Affect Disord; 2019 Mar; 246():252-261. PubMed ID: 30590288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Course of neurocognitive function in first treatment bipolar I disorder: One-year follow-up study.
    Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Haatveit B; Andreassen OA; Melle I; Ueland T
    Psychiatry Res; 2017 Mar; 249():286-292. PubMed ID: 28142102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal relationship between clinical course and neurocognitive impairments in bipolar disorder.
    Martino DJ; Igoa A; Marengo E; Scápola M; Strejilevich SA
    J Affect Disord; 2018 Jan; 225():250-255. PubMed ID: 28841488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of alcohol and illicit substance use on verbal memory among individuals with bipolar disorder.
    Cardoso TA; Bauer IE; Jansen K; Suchting R; Zunta-Soares G; Quevedo J; Glahn DC; Soares JC
    Psychiatry Res; 2016 Sep; 243():225-231. PubMed ID: 27423121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder.
    Martino DJ; Strejilevich SA; Marengo E; Ibañez A; Scápola M; Igoa A
    J Affect Disord; 2014; 167():118-24. PubMed ID: 24955563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Social cognition in bipolar disorder: the role of sociodemographic, clinical, and neurocognitive variables in emotional intelligence.
    Varo C; Jiménez E; Solé B; Bonnín CM; Torrent C; Lahera G; Benabarre A; Saiz PA; de la Fuente L; Martínez-Arán A; Vieta E; Reinares M
    Acta Psychiatr Scand; 2019 Apr; 139(4):369-380. PubMed ID: 30786002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances.
    Volkert J; Kopf J; Kazmaier J; Glaser F; Zierhut KC; Schiele MA; Kittel-Schneider S; Reif A
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):192-202. PubMed ID: 25156468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls.
    Osher Y; Dobron A; Belmaker RH; Bersudsky Y; Dwolatzky T
    Psychother Psychosom; 2011; 80(5):298-303. PubMed ID: 21646824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body Mass Index Predicts Decline in Executive Function in Bipolar Disorder: Preliminary Data of a 12-Month Follow-up Study.
    Dalkner N; Bengesser S; Birner A; Rieger A; Seebauer J; Platzer M; Hamm C; Maget A; Queissner R; Pilz R; Fellendorf FT; Reininghaus B; Strassnig MT; Kapfhammer HP; Weiss EM; Reininghaus EZ
    Neuropsychobiology; 2021; 80(1):1-11. PubMed ID: 32454501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical staging in bipolar disorder: focus on cognition and functioning.
    Rosa AR; Magalhães PV; Czepielewski L; Sulzbach MV; Goi PD; Vieta E; Gama CS; Kapczinski F
    J Clin Psychiatry; 2014 May; 75(5):e450-6. PubMed ID: 24922497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.